News & Awards
Patents
| anti-OX40 | https://pubchem.ncbi.nlm.nih.gov/patent/US-2014308276-A1 |
| anti- HSP-70 | https://patents.google.com/patent/WO2021195557A3/en |
| anti-B7H3 | https://patents.justia.com/inventor/david-piwnica-worms |
| anti-glycosylated PD-L1 | https://patents.justia.com/patent/20220276252 |
| anti-phosphorylated peptides | https://patents.google.com/patent/WO2020132684A2/en |
| anti-aspergillus antigen chimeric receptor | https://patents.justia.com/patent/20220127340 |
and many others (to be completed)...
IDRs
MD Anderson invention disclosure reports, generated by Office of Commercialization (Contact Kayla White)
| IDR-UT-MDACC, Liu, Yong-Jun; Voo, Kui; Ito, Tomoki; Bover, Laura. Anti-human-OX40 antibody, United States, MDA09-027, Filed |
| IDR-UT-MDACC, Liu, Yong-Jun; Voo, Kui; Bover, Laura. Humanized Anti Human-OX40 Antibody, United States, MDA10-008, Filed |
| IDR-UT-MDACC, Liu Yong-Jun; Cao Wei; Bover Laura.. Monoclonal antibodies anti-human Bone Marrow Stromal Protein 2 (BST-2), United States, MDA08-095, Filed |
| IDR-UT-MDACC, Liu, Yong-Jun; Bover Laura. Monoclonal antibodies anti-human TSLPR, United States, MDA08-094, Filed |
| IDR-UT-MDACC, Liu, Yong-Jun; Bover Laura. Monoclonal Antibodies anti-BDCA2, United States, MDA10-095, Filed |
| IDR-UT-MDACC, Liu, Yong-Jun; Bover Laura. Antagonist Anti-CD70 Monoclonal Antibody, United States, MDA11-045, 1/15/2011, Filed |
| IDR-UT-MDACC, Liu, Yong-Jun; Bover, Laura. Anti BDCA2-antibodies for therapy, United States, MDA13-001, 8/31/2012, Filed |
| IDR-UT-MDACC, Orlowski Robert, Jones Richard, Bover Laura. Monoclonal Antibodies To A Novel, Short Form of Heat Shock Protein 70, United States, MDA18-012, 10/6/2017, Filed |
| IDR-UT-MDACC, Bover L, Vien L, Muller F, Khadka S.. Generation and validation of mouse monoclonal anti-human PANK3 antibody, United States, MDA22-052, 2/2/2022, Filed |
And several others filed by our customers.
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.